Related Experiment Video

Updated: Nov 12, 2025

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
06:35

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

17.5K

A case of malignant glaucoma following insertion of Preserflo™ MicroShunt

Corrado Gizzi1, Giacomo Costa1, Roberto Servadei1

  • 1Ospedale Morgagni-Pierantoni, Forlì, Italy.

European Journal of Ophthalmology
|March 19, 2021
PubMed
Abstract

Insights

This case report details malignant glaucoma after Preserflo™ MicroShunt implantation in primary open angle glaucoma. Management involved multiple interventions, including laser and surgery, to resolve the condition.

Area of Science:

  • Ophthalmology
  • Glaucoma Surgery

Background:

  • Primary open angle glaucoma (POAG) management often requires surgical intervention.
  • Preserflo™ MicroShunt (PMS) is a device used to lower intraocular pressure (IOP) in glaucoma patients.

Observation:

  • A 46-year-old male with medically uncontrolled POAG developed malignant glaucoma one day after PMS insertion.
  • The condition recurred multiple times despite various treatments, including laser iridotomy and revision surgery.

Findings:

  • Malignant glaucoma following PMS insertion can occur, potentially due to iris occlusion of the device in shallow anterior chambers.
  • Successful resolution was achieved with pars plana vitrectomy, clear lens extraction, and surgical irido-zonulo-hyaloidectomy.

Implications:

  • This case highlights the importance of recognizing and managing malignant glaucoma post-PMS implantation.
  • Treatment strategies may need to be tailored, considering the potential for device obstruction and recurrent episodes.
Keywords:
InnFocusMalignant glaucomaMicroShuntPreserfloaqueous misdirectionglaucomaglaucoma surgery

More Related Videos

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.6K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.4K

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
938
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
811